M

D

MARTÍNEZ-CUADRÓN , David

Last name: MARTÍNEZ-CUADRÓN

First name: David

September 30, 2022 (v1)

Publication

Metadata-only

Long-Term Outcomes After Autologous Versus Allogeneic Stem Cell Transplantation in Molecularly-Stratified Patients With Intermediate Cytogenetic Risk Acute Myeloid Leukemia: A PETHEMA Study.

Rodríguez-Arbolí, Eduardo Martínez-Cuadrón, David Rodríguez-Veiga, Rebeca

Acute myeloid leukemia (AML) with intermediate risk cytogenetics (IRcyto) comprises a variety of biological enti- ties with distinct mutational landscapes that translate into differential risks of relapse and prognosis. Optimal postremission therapy choice in this heterogeneous patient population is currently unsettled. In the current study, we...

Uploaded on: March 24, 2023